ENTA

Enanta Pharmaceuticals Inc
51.91
-1.47 (-2.75%)

Enanta Pharmaceuticals Inc. (ENTA) Fundamentals

Enanta Pharmaceuticals Inc is an American biotechnology company focused on the research and development of molecule drugs to cure viral infections and liver diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.
SHARE INFORMATION
Market Cap$ 1,114,917,794
Shares Outstanding20,886,433
Float16,156,631
Percent Float77.35%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 86,160,000
Latest Fiscal EPS$ -5.91
Latest Fiscal Date2022-09-30
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions402
Institutional Holdings Date2022-12-31
Institutional Bought Previous 3 Months723,437
Institutional Holdings Percent159.2%
Institutional Sold Previous 3 Months1,896,101
Insider Holdings Date2022-12-31
Insider Bought Previous 3 Months552,648
Insider Holdings Percent7.0
Insider Sold Previous 3 Months28,468
Insider Shares Owned1,461,220
TRADING INFO
52 Week High$ 79.50
52 Week Low$ 37.59
52 Week High Change$ -10.16
21 Day Moving Average$ 49.6971
21 Day Extended Moving Average$ 49.8764
50 Day Moving Average$ 46.6284
50 Day Extended Moving Average$ 48.3332
200 Day Moving Average$ 51.5205
200 Day Extended Moving Average$ 51.9832
10 Day Average Volume141,448
20 Day Average Volume146,259
30 Day Average Volume148,374
50 Day Average Volume152,023
Alpha0.003198
Beta0.4770
Standard Deviation0.151797
R20.028707
7 Day Price Change$ 1.56
7 Day Percent Change3.01%
21 Day Price Change$ 5.23
21 Day Percent Change10.86%
30 Day Price Change$ 6.86
30 Day Percent Change14.75%
Month to Date Price Change$ 6.86
Month to Date Percent Change14.75%
Quarter to Date Price Change$ 6.86
Quarter to Date Percent Change14.75%
180 Day Price Change$ -1.77
180 Day Percent Change-3.21%
200 Day Price Change$ 2.07
200 Day Percent Change4.03%
Year to Date Price Change$ 6.86
Year to Date Percent Change14.75%

Enanta Pharmaceuticals Inc. (ENTA) Key Ratios

PROFITABILITY
EBIT Margin-143.7%
EBITDA Margin-140.3%
Pre-Tax Profit Margin-46.5%
Profit Margin Count-81.96%
Gross Margin0.0%
Profit Margin TOT-81.96%
INCOME STATEMENTS
Revenue$ 58,512,000
Revenue Per Share$ 2.8014
Revenue (3 Years)$ -22.67
Revenue (5 Years)$ -12.96
FINANCIAL STRENGTH
Price to Tangible Book3.30
Total Debt To Equity0.10
Int Coverage0.00
Current Ratio10.50
Leverage Ratio1.20
Quick Ratio10.00
Long Term Debt To Capital0.07
VALUATION MEASURES
PE Ratio-8.60
Enterprise Value$ 840,194,761
Price to Sales19.0545
Price to Free Cash-14.50
PE High Last 5 Years138.90
Price To Book3.30
Price To Cash Flow154.60
PE Low Last 5 Years-22.00
Price to Tangible Book3.30
MANAGEMENT EFFECTIVENESS
Receivables Turnover1.20
Invoice Turnover0.00
Assets Turnover0.20
Return Assets-32.59
Return on Equity-36.91
Return on Capital-30.48

Enanta Pharmaceuticals Inc. (ENTA) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorPricewaterhouseCoopers LLP
CEOJay R. Luly
Emplyoees160
Last AuditUQ
CIK0001177648
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address500 Arsenal Street
Watertown, MA 2472
Websitehttps://www.enanta.com
Facsimile+1 617 607-0530
Telephone+1 617 607-0800
Emailjviera@enanta.com


Your Recent History
NASDAQ
ENTA
Enanta Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.